Discrepancy between financial disclosures of authors of clinical practice guidelines and reports by industrye
Discrepancy between financial disclosures of authors of clinical practice guidelines and reports by industrye
复制标题
DOI:
10.1097/md.0000000000005711
复制
发表时间:
2017-01-01
期刊:
影响因子:
1.6
通讯作者:
Mylonakis, Eleftherios
中科院分区:
文献类型:
--
作者:
Andreatos, Nikolaos;Zacharioudakis, Ioannis M.;Mylonakis, Eleftherios
There is a substantial effort to increase the accuracy of conflicts of interest (COI) reporting, and reduce the influence of COI between physicians and industry, especially as it relates to clinical practice guidelines.We used the newly implemented Open Payments dataset to evaluate the accuracy of COI disclosures of authors of clinical practice guidelines that were either newly published or revised within 2014 and were included in the National Guideline Clearinghouse (NGC) website (maintained by the U.S. Department of Health and Human Services). Authors were considered as having inaccurate COI disclosure if they had not reported all companies from which they had received funds >$5000 in the 12 months preceding the guideline's publication.We identified 223 guidelines that were either newly published (109/223; 48.9%) or revised (114/223; 51.1%) within 2014 and were included in the NGC website. Among the 1329 guideline authors with available Open Payments data, 523 received >$5000 from at least 1 healthcare-associated entity. However, only 56 out of the 523 authors (10.7%) were found to have accurate COI disclosure. The percentage of authors with accurate COI disclosure in revised guidelines was significantly lower than in newly published guidelines (6.8% vs 14.3%; P